| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | CFO | Director +1 more
2 companies
Shenouda Maged is a Chief Financial Officer at RELMADA THERAPEUTICS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 11 buys and 12 sells.
Estimated insider holdings value: $6.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | RLMD Relmada Therapeutics, Inc. | Chief Financial Officer | Buy | 11,665 | $4.12 | $48,059.80 | +1.5% | +41.7% | - | |
| Nov 5, 2025 | RLMD Relmada Therapeutics, Inc. | Chief Financial Officer | Buy | 500,000 | $2.20 | $1,100,000.00 | +173.4% | +51.4% | - | |
| May 20, 2025 | RLMD Relmada Therapeutics, Inc. | Chief Financial Officer | Buy | 200,000 | $0.49 | $97,208.00 | +44.0% | +11.2% | - | |
| Sep 11, 2024 | RLMD Relmada Therapeutics, Inc. | Chief Financial Officer | Buy | 53,432 | $2.80 | $149,700.84 | +37.6% | -84.4% | -49.7% | |
| Jan 31, 2024 | RLMD Relmada Therapeutics, Inc. | Chief Financial Officer | Buy | 32,675 | $3.85 | $125,716.68 | +75.5% | -7.4% | -91.0% | |
| Mar 10, 2021 | RLMD Relmada Therapeutics, Inc. | CFO | Sale+OE | 10,000 | $35.45 | $354,506.63 | -28.3% | -13.8% | -35.7% | |
| Feb 24, 2021 | RLMD Relmada Therapeutics, Inc. | CFO | Sale+OE | 3,000 | $34.18 | $102,529.24 | -33.9% | - | - | |
| Feb 11, 2021 | RLMD Relmada Therapeutics, Inc. | CFO | Sale+OE | 1,428 | $35.39 | $50,542.06 | -39.1% | - | - | |
| Feb 10, 2021 | RLMD Relmada Therapeutics, Inc. | CFO | Sale+OE | 11,372 | $35.17 | $399,910.17 | -40.3% | - | - | |
| Feb 3, 2021 | RLMD Relmada Therapeutics, Inc. | CFO | Sale+OE | 3,200 | $35.04 | $112,133.92 | -41.3% | - | - |